Genetically modified plant
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Genetically modified plants are genetically engineered to contain one or more genes of another species. The aim is to introduce a new trait to the plant species which does not occur naturally in this species, for example resistance to certain pests, diseases or environmental conditions, or the production of a certain nutrient or pharmaceutical agent.
Genetically modified plants are often called "transgenic plants", as they contain one or more transgenes from other organisms, however, this term also includes plants in which the transgene was integrated by naturally occurring processes.
Transformation technology
There are two common approaches to genetically engineer plants: Most transgenic plants are generated by the biolistic method (particle gun) or by Agrobacterium tumefaciens mediated transformation.
In the biolistic method, DNA is bound to tiny particles of gold or tungsten which are subsequently "shot" into plant tissue or single plant cells under high pressure. The accelerated particles penetrate both the cell wall and membranes. The DNA separates from the metal and is integrated into the plant genome inside the nucleus. This method has been applied successfully for many cultivated crops, especially monocots like wheat or maize, for which a transformation with the help of Agrobacterium tumefaciens is less suitable. A disadvantage of this procedure is the damage done to the cellular tissue.
Agrobacteria are natural plant parasites, and their natural ability to transfer genes is used for the development of genetically engineered plants. To create a suitable environment for themselves, these Agrobacteria insert their genes into plant hosts, resulting in a proliferation of plant cells near the soil level (crown gall). The genetic information for tumour growth is encoded on a mobile, circular DNA fragment (plasmid). When Agrobacterium infects a plant, it transfers so-called T-DNA to a random site in the plant genome. The bacterial T-DNA is cut out of the bacterial plasmid and replaced with the desired foreign gene. The bacterium is used as a means of transporting foreign genes into plants (vector).This method works especially well for dicotelydenous plants like potatoes, tomatoes, and tobacco. Agrobacteria are less suitable for introducing foreign genes to crops like wheat and maize.
Desired traits
The first generation of genetically modified plants obtained two major trait types: resistance to insects (Bt crops) and tolerance to herbicides (glufosinate or glyphosate).
Bt crops contain a gene from Bacillus thuringiensis, which enables them to produce an insecticide inside their cells. Although this insecticide, the Bt toxin, acts highly specific, it has been claimed that some Bt crops damage non-target organisms.
Herbicide-tolerant plants withstand the treatment with a broadly active herbicide, which kills all weeds in the field, leaving only the cultivated GM crop unharmed. In countries with a history of several years of GM cultivation, an increasing number of cases of resistant weeds has been reported.
Future generations of GM plants are intended to be suitable for harsh environments, produce increased amounts of nutrients or even pharmaceutical agents, or are improved for the production of bioenergy and biofuels.
Biosafety
Genetically modified plants can spread the transgene to other plants or – theoretically – even to bacteria. Depending on the transgene, this may pose a threat to the environment by changing the composition of the local ecosystem. Therefore, in most countries environmental studies are required prior to the approval of a GM plants for commercial purposes, and a monitoring plan must be presented to identify potential effects which have not been anticipated prior to the approval.
Little research has been conducted on human and animal health. However, in most countries every GM plant is tested in feeding trials to prove its safety, before it is approved for use and marketing. The project GMO-Safety collects and presents biosafety research on GMOs with more in-depth information on this topic.[1]
- See also: biosafety
Coexistence and traceability
In many countries, and especially in the European Union, consumers demand the choice between foods derived from GM plants, conventionally or organically produced plants. This requires a labelling system as well as the reliable separation of GM and non-GM crops at field level and throughout the whole production chain.
Research has demonstrated, that coexistence can be realised by several agricultural measures, such as isolation distances or biological containment strategies.[2]
For traceability, the OECD has introduced a "unique identifier" which is given to any GMO when it is approved. This unique identifier must be forwarded at every stage of processing.[3]
Many countries have established labelling regulations and guidelines on coexistence and traceability. Research projects like Co-Extra, SIGMEA and Transcontainer are aimed at investigating improved methods for ensuring coexistence and providing stakeholders the tools required for the implementation of coexistence and traceability.
External links
- GMO-Compass: News and backgrounds on GM plants, including a database of approvals in the EU
- GMO-Safety: Research on biosafety
- Co-Extra: Research on co-existence and traceability
- SIGMEA: Research on the safe introduction of GMOs in European agriculture
- Transcontainer: Research on biological containment of transgenes
- OECD BioTrack Product Database of Unique Identifiers
References
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
